Introduction {#s1}
============

Endometriosis is a chronic estrogen-dependent disease characterized by endometrial glands and stroma outside the uterus, often in the peritoneal cavity ([@DEW163C45]), with an estimated prevalence of about 10%, and affecting 4--30% of women during their reproductive years ([@DEW163C25]; [@DEW163C7]). Women present chronic pelvic pain, dysmenorrhea, dyspareunia or infertility ([@DEW163C27]; [@DEW163C11]), that can be incapacitating and can negatively affect their quality of life ([@DEW163C23]).

Intrauterine etiology and early-life influences are one of the etiological hypotheses being investigated for endometriosis ([@DEW163C32]; [@DEW163C17]; [@DEW163C5], [@DEW163C8]; [@DEW163C35]; [@DEW163C39]; [@DEW163C48]; [@DEW163C14]; [@DEW163C43]; [@DEW163C44]).

Anogenital distance (AGD) is a sexually dimorphic feature, which is almost twice as long in males than in females, and a biomarker of prenatal hormonal environment ([@DEW163C16]; [@DEW163C24]). In observational studies, AGD is a biomarker of prenatal exposure to endocrine disruptors ([@DEW163C40], [@DEW163C41]; [@DEW163C4]) and androgens during the formation of the reproductive system ([@DEW163C9]; [@DEW163C21]). Prenatal exposure to stressful life events result in a longer (more masculine) AGD in infant girls ([@DEW163C2]), while exposure to anti-androgens results in a shorter (more feminine) AGD in infant males ([@DEW163C40], [@DEW163C41]). In adult women, AGD length is associated with female reproductive function ([@DEW163C29]; [@DEW163C30],[@DEW163C31]; [@DEW163C3]). We hypothesize that a prenatal estrogenic environment resulting in relatively shorter AGD will be associated with higher endometriosis risk. The aim of this study was to assess the relationship between AGD measurements, as a biomarker of intrautero hormonal milieu, and the presence of endometriomas and deep infiltrating endometriosis (DIE) in adulthood.

Materials and Methods {#s2}
=====================

Study population {#s2a}
----------------

This case--control study conducted from September 2014 to May 2015 at the Department of Obstetrics and Gynecology of the University Hospital 'Virgen de la Arrixaca' in the Murcia Region (Spain). Patients were excluded from the study if they were pregnant, or having with oncological treatment or genitourinary prolapse. The age range was 18--50 years of age. Cases (*n* = 114) were women attending the Endometriosis Unit of the Hospital, and included prevalent and newly diagnosed cases. Diagnoses were established by medical history, and confirmed by ultrasounds \[e.g. endometriotic cyst (endometriomas) or DIE\] ([@DEW163C13]; [@DEW163C1]; [@DEW163C19]; [@DEW163C38]; [@DEW163C22]; [@DEW163C45]). Deep endometriosis was defined as endometriosis infiltrating the peritoneum by \>5 mm. Therefore, women with endometriosis were further classified as endometriomas (*n* = 82) and DIE  (*n* = 32) using symptoms, signs and ultrasound findings. When a patient presented both types of endometriosis (DIE and endometriomas), she was classified as DIE. Controls were women without endometriosis attending the gynecological outpatient clinic for routine exams (*n* = 105). Nine controls reported clinical symptoms compatible with endometriosis but the diagnosis was not confirmed by transvaginal ultrasound (TVUS). Written informed consent was obtained from all subjects. This study was approved by the Ethics Research Committee of the University of Murcia.

Gynecological history and physical examination {#s2b}
----------------------------------------------

Cases and controls were interviewed in-person by gynecologists. All participants completed health questionnaires, gynecological and obstetrical histories, and underwent a gynecological examination including TVUS at a scheduled clinical visit. A visual analog scale (0 to 10) was used to measure endometriosis-associated pelvic pain (dysmenorrhea, chronic pelvic pain, dyspareunia, dysuria and dyschezia) at the time of the exam ([@DEW163C46]). Height and weight were measured using a digital scale (Tanita SC 330-S, London, UK). Uterine and ovarian morphology were evaluated with TVUS (Voluson E-8^®^ and 4--9 MHz transducer; General Electric Healthcare, USA). All women having disease were diagnosed by 2D, but for DIE cases, 3D was also used (30% of cases). Two gynecologists using the same methodology performed all clinical evaluations.

Anogenital measurements {#s2c}
-----------------------

Women lay in the lithotomy position with thighs at 45° to the examination table. Using a digital caliper (Stainless Steel Digital Caliper, VWR^®^ International, LLC, West Chester, PA, USA), AGD~AC~ was measured from the anterior clitoral surface to the upper verge of the anus, and AGD~AF~ from the posterior fourchette to the upper verge of the anus (Fig. [1](#DEW163F1){ref-type="fig"}). Two gynecologists unaware of the patient' gynecological status measured each distance three times. Average values of the six measurements were used in the analyses. Figure 1Landmarks for two measurements of anogenital distance (AGD): AGD~AC~, from the anterior clitoral surface to the upper verge of the anus (left) and AGD~AF~, from the posterior fourchette to the upper verge of the anus (right).

Statistical analyses {#s2d}
--------------------

Descriptive statistics are presented using raw data. Continuous variables were compared using unpaired Student T tests, and categorical variables were compared with *χ*^2^ tests. Unconditional multiple logistic regression was used to explore the association between presence of endometriosis (endometriomas and/or DEI) (yes/no) and AGD (in tertiles from the whole distribution of cases and controls, with the highest tertile as reference category) using odds ratios (OR). Age (years) and BMI (kg/m^2^) were included as potential confounders in the model, and vaginal delivery and episiotomy were included as covariates as they may affect AGD. Tests for trend in the ORs across exposure strata for AGD measures were calculated using logistic models that included categorical terms as continuous variables. Coefficients of variation (%CV) were used to assess intra- and inter-examiner variability in AGD measurements. All tests were two-tailed at 0.05 significance level. Analyses were conducted with IBM SPSS 20.0 (IBM Corporation, Armonk, New York, USA).

Results {#s3}
=======

For the whole population, cases were older and had had more birth deliveries than controls, but were similar for other demographic and lifestyle factors (Table [I](#DEW163TB1){ref-type="table"}). AGD~AC~ and AGD~AF~ had normal distributions, were correlated \[Pearson correlation (*r*) = 0.52, *P* \< 0.001\] and had a positive association with BMI (*P*-values \< 0.01). Intra- and inter-examiner CV were 5% and 10% for AGD~AF~ and AGD~AC~, respectively. Intraclass correlation coefficients were above 0.95 for both AGD measurements. Cases showed significantly shorter AGD~AF~ compared with controls. Table IComparison of the general characteristics of controls and cases of endometriomas and deep infiltrating endometriosis (DIE).CharacteristicsControls (*n* = 105)All endometriosis (*n* = 114)*P*-value^c^DIE (*n* = 32)*P*-value^c^Endometriomas (*n* = 82)*P*-value^c^MeanSDMedian5--95MeanSDMedian5--95MeanSDMedian5--95MeanSDMedian5--95Age (years)29.76.031.020.0--39.036.27.537.022.9--48.0\<0.00137.66.137.525.3--47.7\<0.00135.87.836.521.9--48.5\<0.001Body mass index (BMI) (kg/m^2^)23.85.422.217.6--36.223.53.822.518.5--30.80.4723.23.122.618.5--29.70.5823.64.022.518.4--31.20.53Age at menarche (years)11.91.312.09.2--14.012.21.412.010.0--14.00.1612.11.912.09.0--14.00.1612.21.312.010.6--14.00.16Anogenital distance (AGD~AF~) (mm)27.35.726.218.9--38.923.55.822.315.3--33.8\<0.00119.13.518.314.4--27.9\<0.00125.35.624.618.2--35.20.02Anogenital distance (AGD~AC~) (mm)75.711.773.658.1--99.473.812.172.955.6--95.60.2468.912.871.344.1--90.8\<0.0175.711.475.658.3--97.50.99Percentage (%)Alcohol consumption^a^74.575.30.9075.00.9675.30.90Tobacco consumption^b^39.251.50.0957.10.1350.00.15Have had: Endometriosis surgery--36.0--40.6--34.1-- Vaginal delivery21.041.20.00128.10.4746.30.001 Episiotomy16.210.50.223.10.0713.40.60Parity 077.162.376.757.3 116.917.96.722.7 23.618.916.718.7 3+2.40.9--1.3[^2][^3][^4][^5][^6][^7]

Table [II](#DEW163TB2){ref-type="table"} presents AGD measurements in tertiles (or by median for DIE) and ORs. AGD~AF~, but not AGD~AC~, was related to presence of endometriomas and/or DIE (*P*-values, \<0.001--0.04) in the adjusted models. For all cases of endometriosis (endometriomas and DIE), women with AGD~AF~ in the lowest compared with the upper tertile were 7.6-times (95% CI 2.8--21.0; *P*-trend \< 0.001) more likely to have endometriosis (Fig. [2](#DEW163F2){ref-type="fig"}). The strength of the association decreased when the analysis was restricted to women with endometriomas (OR 3.5, 95% CI 1.3--9.4; *P*-trend \< 0.05). Women with DEI and AGD~AF~ below the median were 41.6 times (95% CI 3.9--438; *P*-value = 0.002) more likely to have endometriosis than those above the median. Table IIOdds ratio (OR) for cases of endometriomas and deep infiltrating endometriosis (DIE) versus controls according to tertiles of AGD measures, taking the third tertile as a reference or divided by the median (for DIE).All endometriosis (*n* = 114) versus controls (*n* = 105)AGD in tertiles (median for each tertile)CasesControlsOdds ratio^a^ (95% CI)*P*-trendOdds ratio^b^ (95% CI)*P*-trendOdds ratio^c^ (95% CI)*P*-trendAGD~AF~ 3rd (31.1 mm)26481.0 (reference)1.0 (reference)1.0 (reference) 2nd (24.8 mm)34381.7 (0.9--3.2)2.3 (1.1--5.2)1.8 (0.71--4.4) 1st (19.7 mm)54195.2 (2.6--10.7)\<0.0016.7 (2.6--16.9)\<0.0017.6 (2.8--21.0)\<0.001AGD~AC~ 3rd (86.1 mm)37361.0 (reference)1.0 (reference)1.0 (reference) 2nd (73.6 mm)36370.95 (0.50--1.8)1.3 (0.57--2.9)1.9 (0.75--4.6) 1st (63.3 mm)41321.2 (0.65--2.4)0.681.8 (0.77--4.0)0.402.1 (0.82--5.2)0.26Endometriomas (*n* = 82) versus controls (*n* = 105)AGD in tertiles (median for each tertile)CasesControlsOdds ratio^a^ (95% CI)*P*-trendOdds ratio^b^ (95% CI)*P*-trendOdds ratio^c^ (95% CI)*P*-trendAGD~AF~ 3rd (31.8 mm)21431.0 (reference)1.0 (reference)1.0 (reference) 2nd (25.5 mm)26351.5 (0.74--3.2)2.1 (0.87--5.1)1.7 (0.64--4.4) 1st (21.1 mm)35272.7 (1.3--5.5)0.033.7 (1.5--9.3)0.023.5 (1.3--9.4)0.04AGD~AC~ 3rd (86.6 mm)27351.0 (reference)1.0 (reference)1.0 (reference) 2nd (74.3 mm)27360.97 (0.48--1.9)1.6 (0.69--3.8)2.0 (0.76--5.1) 1st (65.1 mm)28341.1 (0.53--2.2)0.972.1 (0.88--5.2)0.242.6 (0.96--7.2)0.16DIE (*n* = 32) versus controls (*n* = 105)AGD divided by median (median for each group)CasesControlsOdds ratio^a^ (95% CI)*P*-valueOdds ratio^b^ (95% CI)*P*-valueOdds ratio^c^ (95% CI)*P*-valueAGD~AF~ 2nd (30.1 mm)3651.0 (reference)1.0 (reference)1.0 (reference) 1st (20.6 mm)294015.7 (4.5--54.9)\<0.00124.4 (4.1--146)\<0.00141.6 (3.9--438)0.002AGD~AC~ 2nd (81.2 mm)12561.0 (reference)1.0 (reference)1.0 (reference) 1st (67.5 mm)20491.9 (0.85--4.3)0.122.9 (0.85--10.4)0.092.6 (0.69--9.4)0.15[^8][^9][^10][^11][^12] Figure 2Unadjusted and adjusted odds ratio (OR) (95% CI) for the associations of tertiles \[Longer (tertile 3), Medium (tertile 2) and Shorter (tertile 1)\] of AGD~AF~ measurements in relation to presence of all endometriosis (cases; *n* = 114 versus controls; *n* = 105).

Discussion {#s4}
==========

We found a strong association between AGD~AF~ and presence of endometriomas and DIE, suggesting that the intrauterine hormonal milieu during prenatal life may play an important role in the development of endometriosis.

An increased rate of endometriosis was described in women prenatally exposed to diethylstilbestrol ([@DEW163C32]), and women who were regularly fed soy formula as infants were shown to have more than twice the risk of endometriosis compared with unexposed women ([@DEW163C43]).

It has been long argued that endometriosis, an estrogen-dependent disease, may have an intrauterine etiology ([@DEW163C32]; [@DEW163C17]; [@DEW163C5], [@DEW163C8]; [@DEW163C35]). The development of the uterine endometrial gland begins *in utero* and is completed in puberty ([@DEW163C15]). Early hormonal signaling disruptions may result in altered morphology and function from very early on. Evidence of endometriosis has been found in the autopsies of female human fetuses at various gestational ages ([@DEW163C36], [@DEW163C37]). In our study, we were not able to measure specific exposures *in utero* but prenatal exposure to monobutyl phthalate in amniotic fluid has been inversely correlated with the anogenital index in female infants ([@DEW163C20]).

Few studies have explored AGD in women. A longer AGD has been related to higher ovarian follicular number ([@DEW163C29]) and to higher testosterone levels ([@DEW163C31]). Moreover, longer AGD~AF~ in young women is associated with irregularities in their mother\'s menstrual cycle before pregnancy ([@DEW163C30]), suggesting that the prenatal environment may exert a long-lasting influence in the reproductive tract of female offspring. An altered female AGD may also be an important biomarker of the human ovarian dysgenesis syndrome ([@DEW163C6]).

The current study showed significant associations with the presence of endometriomas and DIE for AGD~AF~, but not for AGD~AC~. There is not a clear interpretation for this difference at the moment. Similarly, almost all studies have reported associations for the short (equivalent) measurement (anus-scrotum) in males ([@DEW163C12]; [@DEW163C28]) and females ([@DEW163C31]). However, it might be interesting and useful to take both measures, until a significant body of normative data has been accumulated in adults.

Selection and measurement bias has to be considered. Controls were patients attending the public hospital in the same period, and they stem from the same population from which cases emerged. Although TVUS cannot replace surgery for the diagnosis of noninvasive endometriosis ([@DEW163C34]), TVUS has a relatively high values for sensitivity (93%) and specificity (96%) for endometriomas. Nonetheless, misclassification of disease status may have occurred, but, if present, it would contribute to underestimating the true magnitude of the association. AGD measures were performed by two gynecologists that were not members of the endometriosis unit and were unaware of the patient\'s status.

AGD is an anthropometric measurement that for what is known ([@DEW163C42]) may be stable across the lifespan of an individual. Therefore, the status of the case, prevalent versus incident, should not affect the relationship between AGD and presence of endometriomas and/or DIE. Recently, it has been reported that AGD in adult rats displays a certain degree of plasticity, which may be mediated by modulation of local androgen/estrogen activities ([@DEW163C33]). However, it has also been shown that AGD is stable across the women\'s menstrual cycle ([@DEW163C3]).

In conclusion, our results provide the first evidence of a strong association between a biomarker of hormonal prenatal environment in women and the presence of endometriomas and DIE. Nevertheless, we are cautious in interpreting the results of the associations between AGD~AF~ and DIE, due to the unstable estimates of these relationships. Our results, if confirmed, have important implications for endometriosis in terms of prevention, clinical practice and future research.
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[^1]: The first two authors contributed equally to this manuscript and should be regarded as joint first authors.

[^2]: AGD~AF~: Anogenital distance from the upper verge of the anus to the posterior fourchette.

[^3]: AGD~AC~: Anogenital distance from the upper verge of the anus to the anterior clitoral surface.

[^4]: SD: standard deviation; 5--95: 5th--95th percentile.

[^5]: ^a^Did you ever drink alcoholic beverages with a frequency of at least one a month?

[^6]: ^b^Have you ever smoked?

[^7]: ^c^*T*-student/Mann--Whitney *U*-test or *χ*^2^ test, compared with control subjects.

[^8]: AGD~AF~: Anogenital distance from the upper verge of the anus to the posterior fourchette.

[^9]: AGD~AC~: Anogenital distance from the upper verge of the anus to the anterior clitoral surface.

[^10]: ^a^Unadjusted OR.

[^11]: ^b^OR adjusted by age and BMI.

[^12]: ^c^OR adjusted by age, BMI, vaginal delivery and episiotomy.
